Formic Acid

Formic Acid

SCHEMBL4911274

COc1ccc2ccccc2c1C(S)c1ccsc1C1=NCCCN1.O=CO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 4/20 0.44
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
FGB P02675 1/20 0.36
ALOX15 P16050 1/20 0.36
TNNI3 P19429 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
BRCA1 P38398 1/20 0.36
TNNT2 P45379 1/20 0.36
CASP7 P55210 1/20 0.36
TNNC1 P63316 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RUVBL1 Q9Y265 1/20 0.34
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.30
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4911286 0.84 NISCH (0.37) NISCHGAATSHR
SCHEMBL6743594 0.80 NISCH (0.52) NISCHMEN1KMT2AFGBALOX15
Formic Acid SCHEMBL4911283 0.77 NISCH (0.43) NISCHKMT2ARUVBL1MAPT
SCHEMBL4360959 0.70 NISCH (0.47) NISCHMEN1KMT2ARUVBL1LMNA
Formic Acid SCHEMBL4911292 0.67 SMN1; SMN2 (0.36) NISCHKMT2AMAPK1LMNAMAPT
Formic Acid SCHEMBL4912238 0.66 RUVBL1 (0.43) NISCHRUVBL1MAPTGAATSHR
SCHEMBL1040607 0.66 MAPT (0.58) NISCHMEN1KMT2AFGBALOX15
SCHEMBL31413914 0.66 MAPT (0.58) NISCHMEN1KMT2AFGBALOX15
Formic Acid SCHEMBL4813959 0.64 NISCH (0.51) NISCHMAPTGAATSHR
Hydrochloric Acid SCHEMBL4907533 0.64 NISCH (0.45) NISCHMAPK1LMNAGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof ORE PHARMACEUTICALS, INC. (US) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof MC4R, MC5R, MC3R NISCH 1934/4885MEN1 320/4885KMT2A 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.